American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

Weight loss is a common goal for many, and while diet and exercise remain essential, some turn to medications like Mounjaro ...

Tori Spelling's alarming weight loss has sparked growing concerns, with many fearing her drastic transformation could be ...

A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

When it comes to medically assisted weight loss, there’s two main schools of thought: either weight loss drugs, like the ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly ...

We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...